Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms: a plain language summary.

🤖 Plain-English Summary

Atopic dermatitis (AD, also called atopic eczema) is a skin disease that that can affect a person for a long time and causes red or flaky skin that can be itchy and uncomfortable. Abrocitinib was more effective than dupilumab in quickly improving the signs and symptoms of moderate or severe AD in people who did not show improvement with prescribed medications like creams or ointments.

🔑 Key Findings

• Healthcare providers can prescribe medicated creams and ointments to reduce the visible signs and symptoms of AD, but these treatments are not always enough to keep it under control.
• A new medicine called abrocitinib is taken every day as a tablet.
• Abrocitinib works by slowing a part of the body's defense mechanism, called immune response, that is not functioning properly in AD.

🔗 Related Resources